TY - JOUR
T1 - Review
T2 - Management of diabetes mellitus in the nursing home
AU - Cayea, Danelle
AU - Durso, Samuel C.
N1 - Funding Information:
The research described in this paper was carried out by the Jet Propulsion Laboratory, California Institute of Technology, and was sponsored by the Strategic Defense Initiative Organization, Innovative Science and Technology Office and the National Aeronautics and Space Administration. The work was performed as part of JPL's Innovative Space Technology Center. The authors would like to thank William R. Thogmartin, Allison G. Owens, and Robert L. Toomath for facilities and electronics support.
PY - 2007/5
Y1 - 2007/5
N2 - Diabetes mellitus (DM) is common in older adults and frequently affects residents of nursing homes (NH). Most have complex health status owing to comorbid illness, frailty, and the presence of geriatric syndromes. This complexity increases the risk of adverse events related to treatment. As a result, management of DM in the NH setting requires supreme clinical judgment that balances an understanding of the effects of comorbidity, functional disability, and geriatric syndromes with the resident's healthcare preferences and estimated life expectancy. Developing goals of care and implementing treatment plans requires knowledge of the balance of potential benefits and burdens of certain treatments, including lifestyle modification and pharmacotherapy. Prevention of macrovascular complications through intensive blood pressure and lipid management is achievable in a much shorter time period than the prevention of microvascular complications through intensive glycemic control. Furthermore, it is often necessary and important to address geriatric syndromes, which may significantly impact the resident's quality of life.
AB - Diabetes mellitus (DM) is common in older adults and frequently affects residents of nursing homes (NH). Most have complex health status owing to comorbid illness, frailty, and the presence of geriatric syndromes. This complexity increases the risk of adverse events related to treatment. As a result, management of DM in the NH setting requires supreme clinical judgment that balances an understanding of the effects of comorbidity, functional disability, and geriatric syndromes with the resident's healthcare preferences and estimated life expectancy. Developing goals of care and implementing treatment plans requires knowledge of the balance of potential benefits and burdens of certain treatments, including lifestyle modification and pharmacotherapy. Prevention of macrovascular complications through intensive blood pressure and lipid management is achievable in a much shorter time period than the prevention of microvascular complications through intensive glycemic control. Furthermore, it is often necessary and important to address geriatric syndromes, which may significantly impact the resident's quality of life.
UR - http://www.scopus.com/inward/record.url?scp=34250316098&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34250316098&partnerID=8YFLogxK
M3 - Review article
AN - SCOPUS:34250316098
SN - 1524-7929
VL - 15
SP - 27
EP - 33
JO - Annals of Long-Term Care
JF - Annals of Long-Term Care
IS - 5
ER -